Efficacy and safety of entecavir (ETV) and lamivudine (LVD) in compensated, cirrhotic patients with chronic hepatitis B

被引：0
|
作者：
Chang, Ting-Tsung
Chao, You-Chen
Wu, Shun-Sheng
Tan, Chee Kia
Rosmawati, Mohamed
Lee, Alice
George, Jacob
Brett-Smith, Helena
Zink, Richard
Neo, Boon-Leong
机构：
[1] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan
[2] Tri Serv Gen Hosp, Taipei, Taiwan
[3] Changhua Christian Hosp Hosp, Changhua, Taiwan
[4] Singapore Gen Hosp, Singapore 0316, Singapore
[5] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia
[6] Concord Repatriation Gen Hosp, Concord, NSW, Australia
[7] Univ Sydney, Westmead Hosp, Storr Liver Unit, Westmead, NSW, Australia
[8] Bristol Myers Squibb Pharmaceut Res Inst, Wallingford, CT USA
[9] Bristol Myers Squibb Pharmaceut Res Inst, Singapore, Singapore
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of entecavir (ETV) and lamivudine (LVD) in compensated, cirrhotic patients with chronic hepatitis B
    Senturk, H.
    Schiff, E.
    Brett-Smith, H.
    Zink, R.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S87 - S87
  • [2] Efficacy and safety of entecavir (ETV) and lamivudine (LVD) in compensated, cirrhotic patients with chronic hepatitis B
    Chang, Ting-Tsung
    Chao, You-Chen
    Wu, Shun-Sheng
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A14 - A14
  • [3] Efficacy and safety of entecavir (ETV) and lamivudine (LVD) in compensated, cirrhotic patients with chronic hepatitis B
    Schiff, E
    Lee, WM
    Chao, YC
    Sette, H
    Schalm, SW
    Brett-Smith, H
    Zink, R
    HEPATOLOGY, 2005, 42 (04) : 583A - 584A
  • [4] Efficacy and safety of entecavir (ETV) and amivudine (LVD) in compensated, cirrhotic patients with chronic hepatitis B
    Senturk, H.
    Schiff, E.
    Smith, H. B.
    Zink, R.
    LIVER INTERNATIONAL, 2006, 26 : 54 - 54
  • [5] Efficacy and safety of entecavir and/or tenofovir in hepatitis B compensated and decompensated cirrhotic patients in clinical practice
    Miquel, Mireia
    Nunez, Oscar
    Trapero-Marugan, Maria
    Diaz-Sanchez, Antonio
    Jimenez, Miguel
    Arenas, Juan
    Palau Canos, Antonio
    ANNALS OF HEPATOLOGY, 2013, 12 (02) : 205 - 212
  • [6] EVALUATION OF LONG-TERM ENTECAVIR (ETV) TREATMENT IN STABLE CHRONIC HEPATITIS B PATIENTS SWITCHED FROM LAMIVUDINE (LVD) THERAPY
    Ide, Totsuya
    Sata, Michio
    Shindo, Michiko
    Chayama, Kazuaki
    Toyota, Joji
    Mochida, Satoshi
    Tamita, Eiichi
    Yatsuhashi, Hiroshi
    Hayashi, Norio
    Ishikawa, Hiroki
    Seriu, Taku
    Omata, Masao
    HEPATOLOGY, 2008, 48 (04) : 737A - 738A
  • [7] Cost-effectiveness of substituting lamivudine (LVD) with entecavir (ETV) in chronic hepatitis B (CHB) patients in the public sector of Hong Kong
    Lee, K. K.
    Lee, V. W. Y.
    Yuan, Y.
    VALUE IN HEALTH, 2007, 10 (03) : A162 - A162
  • [8] Efficacy and Safety of Entecavir and/or Tenofovir in Hepatitis B Cirrhotic Patients
    Miquel, Mireia
    Martinez, Oscar Nunez
    Trapero-Marugan, Maria
    Diaz-Sanchez, Antonio
    Jimenez, Miguel
    Arenas, Juan I.
    Palau, Antonio
    GASTROENTEROLOGY, 2010, 138 (05) : S832 - S832
  • [9] Health related quality of life changes after entecavir (etv) or lamivudine (LVD) treatment in lamivudine refractory chronic hepatitis B (CHB) patients - BMS study 026
    Su, J
    Chen, L
    Iloeje, UH
    Cross, AP
    Hindes, RG
    Wilber, RB
    Johnson, JA
    Han, SHB
    Tsai, NC
    Gish, RG
    Sherman, M
    GASTROENTEROLOGY, 2005, 128 (04) : A743 - A743
  • [10] Entecavir (ETV) is superior to lamivudine (LVD) for the treatment of chronic hepatitis B (CHB): results of a phase 3 Chinese study (ETV-023) in nucleoside-naive patients
    Yao, Guangbi
    Chen, Chengwei
    Lu, Weilun
    Ren, Hong
    Tan, Deming
    Wang, Yuming
    Xu, Daozheng
    Liu, Jessica
    Xu, Dong
    Macdonald, Laurie
    Jiang, Michael
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A126 - A126
12345